IP Library Granted Patent US 10,413,444
Granted Patent B2
US 10,413,444 · App. 15/386,377 · Granted Sep 17, 2019

Treatment of ischemia-reperfusion injury by controlling patient temperature

Inventors: Erik Kulstad (Dallas, TX); Hugh Patrick Caherty (Canton, MI)
Assignee: ADVANCED COOLING THERAPY, INC.
A61F7/12A61F7/123A61B2017/00084A61F2007/0054A61F2007/0056A61F2007/0093A61F2007/0095A61F2007/126
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,413,444
App. No.
15/386,377
Granted
Sep 17, 2019
Kind
B2
Abstract

Relatively non-invasive devices and methods for heating or cooling a patient's body are disclosed. Devices and methods for treating ischemic conditions by inducing therapeutic hypothermia are disclosed. Devices and methods for inducing therapeutic hypothermia through esophageal cooling are disclosed. Devices and methods for operative temperature management are disclosed.

Claims (24)

1. A method for treating or preventing ischemia-reperfusion injury by controlling core body temperature in a subject, comprising:

nasally or orally inserting a distal end of an esophageal heat transfer device into the subject;

positioning a heat transfer region of the esophageal heat transfer device in the subject's esophagus, wherein the heat transfer region comprises at least one lumen providing a fluid path for flow of a heat transfer medium;

initiating flow of the heat transfer medium through the fluid path, wherein flow of the heat transfer medium through the fluid path is initiated prior to positioning the heat transfer region of the heat transfer device in the subject's esophagus; and

circulating the heat transfer medium along the fluid path for a time sufficient to control core body temperature in the subject and thereby treat or prevent ischemia-reperfusion injury in the subject.

2. The method of claim 1 , wherein the core body temperature of the subject is maintained within about ±0.5° C. of a goal temperature.

3. The method of claim 2 , wherein the goal temperature is between about 34° C. and about 37° C.

4. The method of claim 1 , wherein the core body temperature of the subject is maintained within about ±0.1° C. of a goal temperature.

5. The method of claim 4 , wherein the goal temperature is between about 34° C. and about 37° C.

6. The method of claim 1 , wherein the esophageal heat transfer device is configured to reduce gastric pressure through gastric ventilation.

7. The method of claim 1 , wherein the at least one lumen is defined by a semi-rigid supply tube comprising a plastic or elastomer selected from the group consisting of ethylene tetrafluoroethylene (ETFE), polytetrafluoroethylene (PTFE), perfluoroalkoxy (PFA), fluorinated ethylene propylene (FEP), and silicone rubber.

8. The method of claim 7 , wherein the semi-rigid supply tube comprises silicone rubber.

9. The method of claim 1 , wherein the subject has experienced or is experiencing myocardial infarction; cardiac arrest; stroke; traumatic brain injury; or acute respiratory distress syndrome.

10. The method of claim 1 , wherein the ischemia-reperfusion injury is a neurological injury.

11. The method of claim 1 , wherein the method does not comprise using a stylet to aid in inserting or positioning the device.

12. The method of claim 1 , wherein at least one lumen is an inflow lumen defined by a semi-rigid supply tube and the semi-rigid supply tube is not inflatable.

13. The method of claim 12 , wherein the heat transfer device further comprises a heat transfer medium input port connected to the inflow lumen.

14. The method of claim 12 , wherein the semi-rigid supply tube comprises a plastic or elastomer selected from the group consisting of ethylene tetrafluoroethylene (ETFE), polytetrafluoroethylene (PTFE), perfluoroalkoxy (PFA), fluorinated ethylene propylene (FEP), and silicone rubber.

15. The method of claim 12 , wherein the semi-rigid supply tube comprises silicon rubber.

16. The method of claim 12 , wherein the heat transfer region includes at least a portion of the semi-rigid supply tube.

17. The method of claim 1 , wherein the heat transfer region does not include a balloon or partially inflatable lumen.

18. The method of claim 1 , wherein the heat transfer region has a diameter of about 1.0 to about 2.0 centimeters.

19. The method of claim 18 , wherein the esophageal heat transfer device comprises a gastric tube that, when the heat transfer region is positioned in an esophagus of the subject, extends into a stomach of the subject.

20. The method of claim 1 , wherein the esophageal heat transfer device comprises a gastric tube that, when the heat transfer region is positioned in an esophagus of the subject, extends into a stomach of the subject.

Assignments (4)
MERGER Recorded Apr 1, 2024
From: AURORA MERGER SUB, INC.
To: ADVANCED COOLING THERAPY, INC.
Reel/Frame 066968/0799 →
CONFIRMATORY LICENSE Recorded May 31, 2017
From: ADVANCED COOLING THERAPY, INC
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 042642/0118 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2016
From: KULSTAD, ERIK; CAHERTY, HUGH PATRICK
To: ADVANCED COOLING THERAPY, LLC
Reel/Frame 041116/0698 →
MERGER Recorded Dec 21, 2016
From: ADVANCED COOLING THERAPY, LLC
To: ADVANCED COOLING THERAPY, INC.
Reel/Frame 041118/0816 →
Continuity (7)
Continuation 13482581 · May 29, 2012
Continuation In Part 13021828 · Feb 7, 2011
Continuation In Part 13021820 · Feb 7, 2011
Continuation In Part 13021805 · Feb 7, 2011
Continuation 12713644 · Feb 26, 2010
Provisional Application 61155876 · Feb 26, 2009
Related Publication 20170100281A1 · Apr 13, 2017
Cited By (1)
US 12,268,631